HDL inflammation and atherosclerosis: current and future perspectives

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Atherosclerosis Pathogenesis

Background:

• High-density lipoprotein (HDL) is integral to cardiovascular health.
• Reduced HDL levels are linked to impaired cholesterol clearance and vascular inflammation.
• Atherosclerosis development is associated with early inflammatory responses.

Purpose of the Study:

• To review recent findings on the role of HDL in cardiovascular disease.
• To provide an educational overview of HDL's biochemical, cellular, and molecular aspects.
• To explore therapeutic strategies targeting HDL modulation for cardiovascular risk reduction.

Main Methods:

• Literature review of recent studies on HDL and cardiovascular disease.
• Analysis of biochemical, cellular, and molecular mechanisms of HDL.
• Synthesis of current understanding regarding HDL's role in atherosclerosis.

Main Results:

• Low HDL concentrations hinder cholesterol efflux from the vascular wall.
• HDL deficiency contributes to the inflammatory processes in atherosclerosis.
• Recent research highlights potential for HDL-modulating therapies.

Conclusions:

• HDL's function in cholesterol homeostasis is critical for preventing cardiovascular disease.
• Understanding HDL's multifaceted roles offers promising therapeutic targets.
• Modulating HDL levels represents a potential strategy to mitigate cardiovascular risk.